{
  "url": "https://struct.news/briefs/edgewises-cash-rose-as-its-losses-and-clinical-spending-widened",
  "title": "Edgewise’s cash rose as its losses and clinical spending widened",
  "summary": "Cash reached $72.3 million at June 30, even as six-month operating cash use climbed to $85.0 million.",
  "published_at": "2026-08-06T12:12:21.353301+00:00",
  "publisher": "Struct",
  "usage": "Figures are as reported by the company. Quote with attribution to the source filing.",
  "company": {
    "name": "Edgewise Therapeutics, Inc.",
    "ticker": "EWTX",
    "cik": "1104659",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "source_filing": {
    "form": "10-Q",
    "filed": "2026-08-06",
    "accession": "0001104659-26-091670",
    "url": "https://www.sec.gov/Archives/edgar/data/1710072/000110465926091670/ewtx-20260630x10q.htm"
  },
  "comparison_filing": {
    "form": "10-Q",
    "filed": "2025-08-07",
    "url": "https://www.sec.gov/Archives/edgar/data/1710072/000155837025010655/ewtx-20250630x10q.htm"
  },
  "reported_figures": [],
  "watch_next": [],
  "related_tickers": [
    "EWTX"
  ],
  "disclaimer": "Descriptive reporting of filed results. Not investment advice, and contains no forecast or recommendation."
}